Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Sponsor: Fred Hutchinson Cancer Center
Summary
This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
Official title: Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1647
Start Date
2022-07-24
Completion Date
2026-05-01
Last Updated
2025-05-28
Healthy Volunteers
Yes
Conditions
Interventions
Experimental Smoking Cessation Program
Participate in Quitbot experimental cessation program
Control Smoking Cessation Program
Participate in Quitbot control cessation program
Locations (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States